Ciro Francesco Ruggiero

Author

Istituti di Ricovero e Cura a Carattere Scientifico

Also Known As

C Ruggiero, Ciro F. Ruggiero, Ciro Francesco Ruggiero

Publications

451

Citations

H-Index

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico Sapienza University of Rome Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"Magna Graecia University The Ohio State University

About

Ciro Francesco Ruggiero is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in health sciences, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	36
2	Medicine	1	1	36
3	Cell Biology	1	1	36
4	Immunology	1	1	36
5	Cell Signaling	1	1	36

Ciro Francesco Ruggiero

Publications

265

Citations

H-Index

Page 1

	Year	Citations
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma Luigi Fattore, Ciro Francesco Ruggiero, Maria Elena Pisanu, Cell Death and Differentiation	2018	69
Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts Vera Hirsh, Sandro Pignata, Melissa Bersanelli, Journal of Translational Medicine	2017	43
ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma: Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin Ciro Francesco Ruggiero, Debora Malpicci, Luigi Fattore, Cancers ImmunologyAdaptive ResistanceImmunotherapyMelanoma CellsTumor Biology	2019	36
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance Luigi Fattore, Giordana Cafaro, Marta Di Martile, Oncogene	2022	36
In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma Luigi Fattore, Virginia Campani, Ciro Francesco Ruggiero, International Journal of Molecular Sciences	2020	29
Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts David Carbone, Michael F. Sharpnack, Kai He, Journal of Translational Medicine	2018	28
Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma Ciro Francesco Ruggiero, Luigi Fattore, Irene Terrenato, Theranostics	2022	24

Page 1